An orally available M(pro)/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.
一种口服有效的 M(pro)/TMPRSS2 双特异性抑制剂,在体内具有强大的抗冠状病毒功效
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-60832-z
Shuai Huiping, Qiao Jingxin, Yoon Chaemin, Zhang Guo, Hou Yuxin, Xia Xiaoyan, Wang Lei, Deng Xinyue, Wang Yifei, Li Qingquan, Du Lianzhao, Liu Yuanchen, Zhou Minmin, Wong Hoi Ting, Hu Jiaheng, Liu Huan, Hu Bingjie, Wang Dong, Su Jingyi, Pan Yuying, Ye Yongtao, Chen Yan, Fang Zhen, Xia Ziyi, Chai Yue, Shi Jialu, Wang Yang, Zhu Tianrenzheng, Zhang Honglei, Yuan Shuofeng, Zhou Jie, Chan Jasper Fuk-Woo, Yuen Kwok-Yung, Xu Chunfu, Lei Jian, Yang Shengyong, Chu Hin